NCT06090565View on ClinicalTrials.gov

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

PHASE4CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

December 22, 2022

Conditions
Gonorrhea
Interventions
DRUG

Cefixime

Two 400 mg tablets will be administered orally to equal a 800 mg dose.

DRUG

Doxycyclin

One 100 mg tablet will be administered orally twice a day for 7 days

DRUG

Ceftriaxon

Dose of 1 g intramuscular one time

DRUG

Azithromycin

Four 500 mg tablets will be administered orally to equal a 2 g dose.

Trial Locations (2)

15000

Venereology Prague, Medicentrum Beroun, Prague

18081

University Hospital Bulovka, Prague

All Listed Sponsors
collaborator

Örebro University, Sweden

OTHER

lead

Bulovka Hospital

OTHER

NCT06090565 - Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea | Biotech Hunter | Biotech Hunter